Jw Life Science Corp Free Cash Flow Generation Index
Jw Life Science Corp free cash flow generation index. Jw Life Science Corp (234080) has a Free Cash Flow Generation Index of 0.91x as of June 2026. Free cash flow of ₩15.81 Billion represents 1% of operating cash flow (₩17.43 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Jw Life Science Corp (2015–2025)
Free cash flow generation index of Jw Life Science Corp from 2015 to 2025. Historical FCF Generation Index trend for Jw Life Science Corp across 11 annual periods. See Jw Life Science Corp (234080) flexibility index to measure the company's free cash flow as a share of total liabilities.
Jw Life Science Corp Free Cash Flow Generation Index by Year (2015–2025)
Jw Life Science Corp free cash flow generation index by year from 2015 to 2025. Year-by-year Free Cash Flow Generation Index for Jw Life Science Corp. For the full cash flow conversion analysis, see 234080 operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.67x | ₩27.10 Billion | ₩40.54 Billion | ₩13.43 Billion | ▼ -16.1% |
| 2024 | 0.80x | ₩40.38 Billion | ₩50.69 Billion | ₩10.31 Billion | ▲ +2.1% |
| 2023 | 0.78x | ₩29.31 Billion | ₩37.57 Billion | ₩8.27 Billion | ▲ +88.9% |
| 2022 | 0.41x | ₩5.84 Billion | ₩14.13 Billion | ₩8.29 Billion | ▲ +15.7% |
| 2021 | 0.36x | ₩10.77 Billion | ₩30.17 Billion | ₩18.98 Billion | ▼ -45.3% |
| 2020 | 0.65x | ₩30.52 Billion | ₩46.75 Billion | ₩15.93 Billion | ▼ -0.5% |
| 2019 | 0.66x | ₩15.92 Billion | ₩24.28 Billion | ₩8.09 Billion | ▼ -7.3% |
| 2018 | 0.71x | ₩25.57 Billion | ₩36.13 Billion | ₩10.04 Billion | ▲ +18.2% |
| 2017 | 0.60x | ₩13.20 Billion | ₩22.05 Billion | ₩8.77 Billion | ▼ -67.3% |
| 2016 | 1.83x | ₩29.45 Billion | ₩16.08 Billion | ₩13.37 Billion | ▼ -3.3% |
| 2015 | 1.89x | ₩49.03 Billion | ₩25.90 Billion | ₩23.14 Billion | — |